Expert Talk
AI/ML Driving Clinical Outcomes
I think the convergence of AI and machine learning with pharma marketing is going well beyond building brands
3D Printing for Special Patient Populations
Adoption increases when personalisation translates into visible clinical benefit and simpler use In pediatrics
Why the Pharmaceutical Industry Needs CDMOs and Cold Chain Collaboration
Distribution of lifesaving pharmaceuticals across the globe is incredibly complex At each stage from warehouse
PARADIGM SHIFT TOWARDS THE DEVELOPMENT OF BIODEGRADABLE DRUGS
The increasing recognition of pharmaceutical contamination in the environment has led to a shift in thinking
Digital Twins in Autonomous Biomanufacturing and Precision Engineering for Next-generation RNA Vaccines
The integration of AI with digital twins DTs revolutionises LNP optimisation through multiscale modeling approaches
Navigating Regulatory Complexities in Global Clinical Trials
The New Drugs and Clinical Trials Rules represented a watershed moment in Indias regulatory approach
OLIGONUCLEOTIDE THERAPEUTICS
Where are we and what lies ahead
I think the past decade truly represents a watershed moment for oligo therapeutics We witnessed the dramatic
Diversity and Inclusion in Clinical trials
Historical disparities in clinical trial participation have significantly compromised the generalisability of drug safety
Next Generation Drug Delivery
Advancing container closure systems for enhanced therapeutic performance
Advanced drug delivery technologies represent a convergence of innovative materials science
Impact of AI (LLMs & SLMs) in Clinical Trials for Precision Medicine
In the realm of healthcare and oncology data sources primarily fall into two categories
